The model could lead to more targeted treatments for the disease More: Lab-grown lung cancer cells show potential to revolutionise treatment Source: News
read moreMerck has handed out another hefty raise to CEO Rob Davis, boosting his compensation by 13% to $23.2 million in 2024, according to the company’s 2025 proxy statement. More: Merck granted Rob Davis a pay boost to .2M, inching CEO’s
read moreAfter Sun Pharma appealed an injunction handed down in New Jersey federal court in November that blocked the U.S. launch of its alopecia med Leqselvi, the U.S. Court of Appeals for the Federal Circuit on Wednesday ruled in favor of
read moreAsk a healthcare professional to name a psychiatric medicine and chances are they’ll say a brand approved at least 10 years ago. That finding, which comes from a ZoomRx survey, points to the challenge facing new market entrants as they
read moreAs it advances a monoclonal antibody targeting Guillain-Barré syndrome, Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. More: Annexon rolls out Guillain-Barré awareness campaign for HCPs amid promising results for targeted therapy Source: fierce
read moreReckitt Beckiser and Organon are laying off employees in New Jersey as both companies are undergoing separate restructurings. More: Mucinex maker Reckitt lets go of 190 staffers in NJ while Organon lays off 93 amid restructuring efforts Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals